P-260: Daratumumab (DARA) plus bortezomib and dexamethasone (D-Vd) or lenalidomide and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): subgroup analyses of CASTOR and POLLUX
Title:
P-260: Daratumumab (DARA) plus bortezomib and dexamethasone (D-Vd) or lenalidomide and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): subgroup analyses of CASTOR and POLLUX
Author:
Mateos, MarĂa-Victoria Richardson, Paul Weisel, Katja Moreau, Philippe San-Miguel, Jesus Goldschmidt, Hartmut Orlowski, Robert Sonneveld, Pieter Reece, Donna E. Suzuki, Kenshi Bahlis, Nizar Yoon, Sung-Soo Spencer, Andrew Nooka, Ajay Hungria, Vania Plesner, Torben Yehuda, Dina Ben Pei, Huiling Mayo, Wendy Garvin Gai, Xue Carey, Jodi Carson, Robin Dimopoulos, Meletios A.